MPT 64 Antigen detection for Rapid confirmation of M.tuberculosis isolates by Vijay GS Kumar et al.
TECHNICAL NOTE Open Access
MPT 64 Antigen detection for Rapid confirmation
of M.tuberculosis isolates
Vijay GS Kumar1*, Tejashree A Urs2 and Rajani R Ranganath3
Abstract
Background: A new rapid Immunochromatographic test kit(SD MPT64TB Ag Kit) for detection of MPT 64 Antigen
in M. tuberculosis isolates using mouse monoclonal MPT 64 Antibody developed by SD Bioline, South Korea was
evaluated for rapid identification of M. tuberculosis isolates. We also assessed the sensitivity, specificity and
predictive values of this kit. The test kit has an excellent sensitivity, specificity, negative predictive value & positive
predictive value. This rapid method is found to be a reliable, rapid and cheaper method for confirming MTB
culture isolates in resource poor laboratories. Material/methods: 54 culture isolates of M. tuberculosis in broth & on
LJ medium, 12 Non mycobacterial isolates, 10 Non tubercular (NTM) rapidly growing Mycobacteria isolated from
pus & 5 smear positive sputum samples were tested for detection of MPT64 antigen using the SD Bioline
immunochromatography (ICT)test kit. H37 RV strain was employed as the positive reference control.
Findings: H37 RV strain showed the presence of MPT64 antigen band. Similar band was formed in all the 54 MTB
isolates tested proving 100% sensitivity. MPT64 band formation was not detected in any of the other test isolates
which proved the 100% specificity of the test kit. Both PPV & NPV were 100%.
Conclusion: Tuberculosis is a global pandemic. Rapid identification of MTB culture isolate is very important for
drug susceptibility testing. MPT 64 TB Ag detection ICT kit is a rapid, reliable method; it can be a substitute for the
molecular identification methods.
Introduction
Tuberculosis (TB) is a Global pandemic & India is the
major TB endemic country. Emergence of multi drug
resistance(MDR) in M. tuberculosis(MTB) & the TB-
HIV AIDS nexus is posing serious therapeutic problems
and hampering the goal of WHO in containing this
dreadful disease in India. Slow growing nature of MTB
along with the tedious, risky & cumbersome identifica-
tion tests collectively has led to long delay in antituber-
cular susceptibility testing. This prolonged time needed
for correct identification of MTB isolates is probably
one of the factors contributing to increase of TB cases
in India. Automated culture systems like Bactec 460,
MBBacT (Bio Merieux, France), MGIT have significantly
reduced the turn around time for culture, but do not
help in differentiating MTB & MOTT. Confirmatory
Identification of M. tuberculosis (MTB) is still being
done by conventional biochemical methods. These tests
are laborious, time consuming and require elaborate
safety precautions. During this long and tedious process,
an infected individual continue to spread the disease to
many other susceptible individuals. The recent objective
of WHO is to reduce the time for culture, identification,
and drug resistance detection to as short as 2 days by
employing Line probe assays. This method requires a
specialized set up, trained personale & is not suitable
for resource poor countries.
An alternative rapid and reliable method of Identifying
MTB culture isolates was being continuously searched
by the researchers. The hard work paid dividends in the
form of identifying a 28kDa antigen called MPT64
which is specific for MTB and not found in BCG strains
[1] Recently it has been shown that native as well as
recombinant MPT64 will distinguish between MTB
infection & BCG vaccinated individuals [2] This antigen
detection in culture isolates has been found to be a
highly specific, sensitive and rapid method of confirming
MTB isolates. SD TB Ag MPT 64 Rapid (Standard
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Diagnostics, Seoul, South Korea) has manufactured an
Immunochromatographic tests (ICT) using Monoclonal
Antibodies against MPT64 antigen for confirmation of
MTB isolates [3,4]
In this direction we evaluated the clinical usefulness,
specificity, sensitivity, positive predictive (PPV) & Nega-
tive predictive value (NPV) of a the commercial Immu-
nochromatographic test kit, SD TB Ag MPT 64 Rapid
to prove the specificity of MPT 64 Ag to only MTB
complex.
Materials and methods
54 MTB confirmed isolates, one H37RV culture, 10
MOTT isolates from pus, 12 Gram pos & Gram nega-
tive bacterial isolates from sputum & Urine (Table 1)
were tested for the presence of MPT64 antigen by
Immunochromatographic method.
Methods
Manufacturer’s instructions were followed during the
test. The entire test procedure was carried out inside a
biosafety cabinet category -II (BSC-II).
3- 4 colonies from L.J. Medium isolates & H37 Rv
strain were emulsified in 200 μl. of extraction buffer.
The buffer was vortexed, 100 μl from this buffer was
inoculated in to the sample well of the ICT cassette.100
μl of the culture positive broth (BacT/alert MP bottles)
was directly inoculated into the test cassette. Similarly
3-4 culture colonies of each non mycobacterial isolates
(E. coli, K. pneumoniae, S. typhi, P. aeruginosa, Acineto-
bacter baumanii, S. aureus) were emulsified in the buf-
fer & 100 μl was inoculated in to the sample well.
5 smear positive samples after initial homogenization
were further processed by adopting different methods.
One sample was centrifuged at 3000 rpm for 10 mts,
100 μl of the supernatant was inoculated in to the sam-
ple well. 100 μl from each of the other two sputum sam-
ples was mixed with 200 μl of the buffer & 100 μl from
this was inoculated in to the sample well, 100 μl from
the other two sputum samples was directly inoculated
into the sample well.
The inoculated ICT cassettes were kept at room tem-
perature & were examined at the end of 20 minutes.
Pink band in the ‘C’ region confirmed test validity.
Additional pink band in the ‘T’ region was interpreted
as positive for MPT64 Ag. Only pink band in the ‘C’
region and no band in the ‘T’ region were considered
negative for MPT 64 antigen. No band in ‘C’ region was
interpreted as invalid test.
Results
The control band(C band) was seen in all the 77 sam-
ples tested validating the test. H37 Rv control showed
the appearance of pink band in the test region (T band)
confirming the presence of MPT 64 antigen. 53 M.
tuberculosis isolates showed the dark pink band in the
test region confirming the presence of MPT 64 Ag in
these isolates. One isolate showed a faint pink band for-
mation (54/54). The band intensity is probably related
to the antigen concentration in the test sample or it
could be due to any mutation in the isolate. The sensi-
tivity of the test kit was 100%. The isolate showing faint
band has been sent for genetic characterization. None of
the other 22 test samples including the MOTT isolates
showed the pink band formation, indicating the absence
of MPT64 Ag in these isolates. (Table 2). This proved
the specificity of the ICT (100%).
The study also evaluated the ability of SD TB MPT 64
Ag Rapid ICT kit for antigen detection in smear positive
sputum samples, no band appeared in all the 5 sputum
samples tested at the end of 20 mts, but the band
appeared after overnight incubation. Probably modifica-
tion of the antigen extraction method leading to
increased antigen concentration is needed for this rapid
test to be used for identification of MTB in clinical sam-
ples. The negative test cassettes were examined for test
band appearance after overnight incubation at room
temperature, none of these showed the test band.
Discussion
Tuberculosis is an endemic disease of great antiquity. It
has conquered the entire world and has not spared any
race or creed. Tuberculosis (TB) is a major public health
problem in India. India accounts for one-fifth of the glo-
bal TB incident cases. Each year nearly 2 million people
in India develop TB, of which around 0.87 million are
infectious cases. It is estimated that annually around
330,000 Indians die due to TB. TB is one of the leading
Table 1 Sample distribution




H37Rv 1 0 01
MTB culture isolates 54 0 54
Nontubercular Mycobacteria 10 10 10
Non mycobacterial isolates 12 12 12
Total 77 22 77
Table 2 MPT64 Test results





H37Rv 1 0(100%) 01(100%)
MTB culture isolates 54 00(100%) 54(100%)
Nontubercular Mycobacteria 10 10(100%) 00(100%)
Non mycobacterial isolates 12 12(100%) 00(100%)
Total 77 22 55
Kumar et al. BMC Research Notes 2011, 4:79
http://www.biomedcentral.com/1756-0500/4/79
Page 2 of 4
causes of mortality in India killing 2 persons every three
minutes, nearly 1,000 every day. Early diagnosis well
supported by a Mycobacteriology laboratory equipped to
perform culture, identification and drug susceptibility
testing of Mycobacterium tuberculosis from clinical spe-
cimens is vital in the management of tuberculosis
patients. The automated systems have improved the
speed of isolation but there is a need for rapid identifi-
cation of MTB isolates. Novel technologies for rapid
identification of the culture isolates and Anti tubercular
drug resistant isolates has become a top priority not
only in TB Research but also for diagnosis & treatment
purposes.
The modern molecular methods are not economically
suitable for resource poor laboratories. A cheap, rapid &
reliable identification test method will be of enormous
help in resource poor countries. The new rapid Immu-
nochromatographic methods have been found to be
such ideal diagnostic aid in TB control programme
The main aim of this study was to evaluate a rapid &
economically feasible test which accurately identifies
\MTB isolates grown in culture [1]. Clinically and thera-
peutically differential identification of M. tuberculosis
from mycobacteria other than M. tuberculosis (MOTT)
is very important. Most of the Mycobacteriology labora-
tories identify MTB using conventional biochemical
tests. These tests are not labor sensitive & need special
bio safety equipments. Biological, molecular and immu-
nological studies of MTB complex have resulted in iden-
tification of different useful antigens, some of which are
specific to MTB complex. Tuberculosis MPT64 also
termed as protein Rv1980c is one such antigen [5,6]. It
is a protein secreted by actively growing MTB strains
[7]. The MPT 64 antigen is absent in BCG strains, M.
bovis &M. leprae and in other Mycobacterial species.
This has been confirmed by Cloning and sequencing of
MPT64 gene of H37Rv culture filtrate [8]. The ongoing
MTB research studies have proved the immunogenic
property of MPT64 [9,10]. MPT64 antigen and culture
filtrate protein (CFP-2) antigens are restricted antigens
of MTB complex and are found to be TB specific candi-
date antigens [11]. It has also been proved that MPT 64
antigen is found only in Viable & actively dividing cells
of M. tuberculosis [5]. Acommercial ICT test kit (Capi-
lia TB kit) was evaluated for Rapid Identification of 784
culture isolates by employing Accu probe -MTB as the
reference method for MTB identification & comparative
evaluation of the rapid kit. The sensitivity of the rapid
test kit was found to be 99.2%. (381/384). An important
observation in this study was no false positive results
were detected. Thus the study found the specificity of
the rapid ICT test as 100% & have concluded that the
Capilia TB ICT test kit is an useful method for rapid
& routine identification of MTB isolates [3,12].
Comparative evaluation studies of Rapid ICT test kits &
conventional biochemical tests with Accu probe sequen-
cing has proved that these ICT’s have 100% specificity &
a sensitivity of 97%. The Rapid ICT’s are economically
cheaper & the turnaround time for specifically identify-
ing MTB is markedly reduced [4]. SD MPT 64 TB Ag
rapid ICT kit with its Very high sensitivity, high specifi-
city, no false positivity & the low tech rapidity scores
over the molecular methods [1]. The sensitivity, specifi-
city, positive predictive & negative predictive values of
the SD AgMPT64 kit was found to be 97%, 100%,! 100%
& 92% respectively [13]. No false positive or false nega-
tive results were detected in the study. ICT’s detecting
MPT64 antigen could be the replacement for conven-
tional identification tests in the days to come [1]. The
simplicity of the method, low cost compared to molecu-
lar methods for confirmation of MTB isolates makes the
rapid ICT’s an excellent choice for use in TB diagnostic
laboratories. In the present study the sensitivity of SD
Ag MPT 64 kit was 100%. All 54 MTB isolates showed
same band similar to H37Rv culture. None of the non
mycobacterial species & the non tubercular mycobacter-
ial species tested showed Band formation for MPT64
antigen & absence of this antigen in other non tubercu-
lar isolates indicated the specificity of MPT 64 antigen
for MTB only.
The positive & Negative predictive values in the study
was 100%,. A lower NPV (92%) was observed in one of
the study which found 100% PPV [13]. The lower NPV
can only be explained as false negative result. In con-
trast 100% NPV (260/260) was detected in one of the
study [14]. There are reports of false negativity in ICT
methods among few genetically confirmed MTB strains.
This is attributed to mutation occurring in the specific
gene of MTB isolates [15]. One study using Capilia TB
ICT kit detected false negativity in 6 MTB isolates [4].
Genomic analysis showed mutation in all 6 strains. This
is a common feature encountered with both commercial
kits.
There was no difference in the predictive values, sensi-
tivity & specificity for isolates grown in liquid culture
medium and on L.J. Medium. The intensity of the band
was more prominent with the liquid cultures. During
the study an attempt was made to evaluate the ICT for
identification of MPT 64 antigen in smear positive spu-
tum samples. Further improvement in antigen extraction
method may help in employing SD MPT 64 TB Ag
Rapid kit for antigen detection in clinical samples. Simi-
lar observations have been expressed by other research-
ers. Cost effective analytical studies of SD MPT64 TB
Ag ICT and other rapid ICT’s in comparison with mole-
cular methods and culture combined with conventional
biochemical tests have shown that SD MPT 64 TB Ag
ICT is more economical than the other two methods.
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This test does not require any sophisticated equipments
or specialized trained persons [16].
Conclusion
The SD MPT 64 TB Ag Rapid ICT kit is a simple, reli-
able, rapid, low-tech identification kit which can be used
as a diagnostic tool in resource poor diagnostic centers
for accurate identification of MTB isolates. The rapidity
of this test will markedly reduce the turnaround time in
MTB culture & Drug susceptibility testing. Indirectly
these tests contribute in a significant way in Tuberculo-
sis control programmes. The low cost, rapidity, High
specificity, Sensitivity, PPV & NPV of the MPT 64 anti-
gen detection makes the ICT’s a very useful diagnostic
tool. India being the major endemic country of tubercu-
losis is in need of introducing the rapid diagnostic
methods more than any other country in the world.
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